Description

Rovamicin (Spiramycin) Coated Tablets 3000000 IU №10

Ingredients:

Each coated tablet contains 3000000 IU of Spiramycin as the active ingredient.

Dosage:

The usual dosage for adults is one tablet three times a day. Dosage may vary based on the condition being treated. Consult a healthcare professional for personalized recommendations.

Indications:

Rovamicin coated tablets are indicated for the treatment of bacterial infections sensitive to spiramycin. These may include respiratory tract infections, skin and soft tissue infections, and more.

Contraindications:

Do not use Rovamicin tablets if you are allergic to spiramycin or any other ingredients in the formulation. Pregnant or breastfeeding women should consult a doctor before use.

Directions:

Swallow the tablets whole with a full glass of water. Do not crush or chew the tablets. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence:

Spiramycin, the active ingredient in Rovamicin tablets, is a macrolide antibiotic with demonstrated efficacy against a wide range of gram-positive bacteria. Studies have shown its effectiveness in treating various infections, including toxoplasmosis and respiratory tract infections. Research published in the International Journal of Antimicrobial Agents highlights spiramycin’s role in combating bacterial resistance.

Additional Information:

Rovamicin tablets offer a convenient and effective treatment option for bacterial infections. The coated formulation ensures optimal absorption and bioavailability of spiramycin, enhancing its therapeutic effects. It is important to complete the full course of treatment as prescribed to achieve the best outcomes and prevent the development of antibiotic resistance.

Pharmacological Effects: Spiramycin acts by inhibiting bacterial protein synthesis, leading to the suppression of bacterial growth and replication. It penetrates well into tissues, making it effective against intracellular pathogens.

Clinical Trials: Clinical trials have demonstrated the safety and efficacy of Rovamicin tablets in treating bacterial infections. A study published in the Journal of Antimicrobial Chemotherapy showed high rates of clinical success and tolerability in patients receiving spiramycin for respiratory infections.